Yahoo Malaysia Web Search

Search results

  1. 3 days ago · Anne Wojcicki, Linda Avey, and Paul Cusenza founded popular consumer genetics company 23andMe in 2006, yet Cusenza is often omitted. This is his co-founder story.

  2. 1 day ago · Their work with public biobank projects and resulting publications have previewed the exciting potential for metabolomics in prediction. We believe this collaboration will ultimately help our customers lead longer, healthier lives,” said Anne Wojcicki, CEO and Co-Founder of 23andMe.

  3. 1 day ago · “We are truly impressed with Nightingale Health’s capabilities in blood biomarker testing," Anne Wojcicki, CEO and cofounder of 23andMe, said in a statement. "Their work with public biobank projects and resulting publications have previewed the exciting potential for metabolomics in prediction.

  4. 1 day ago · Anne Wojcicki, CEO and Co-Founder of 23andMe, expressed confidence in the potential benefits of the collaboration, highlighting Nightingale's proven expertise in blood biomarker testing. Teemu Suna, CEO and Founder of Nightingale Health, echoed this sentiment, emphasizing the partnership's alignment with Nightingale's strategy to penetrate the ...

  5. 1 day ago · What I found surprised me, because as you know the personal DNA testing marketing is largely dominated by 23andMe,(1) which was founded in 2006 by Paul Cusenza, Linda Avey and Anne Wojcicki. Cusenza left the company in 2007 and Avey followed his example in 2009 leaving Wojcicki in charge as the remaining founder and long-term CEO of the company.

  6. 1 day ago · We believe this collaboration will ultimately help our customers lead longer, healthier lives,” said Anne Wojcicki, CEO and Co-Founder of 23andMe. “We are enthusiastic about long-term ...

  7. 4 days ago · Endo Health, a digital healthcare startup based in Silicon Valley, has secured pre-seed investments from US VC Andreessen Horowitz (a16z) and prominent angel investor Anne Wojcicki, CEO of 23andMe. Including its first investment from Krew Capital in February this year, the cumulative investment exceeds 1.3 billion KRW.